The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90 - Wikidata - wikimedia - TriplyDB

The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90

The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90

http://www.wikidata.org/entity/Q33466002

about

Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Defining the roles for Vpr in HIV-1-associated neuropathogenesis.HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.Arcelis AGS-004 dendritic cell-based immunotherapy for HIV infection.

P2860

Q33637584-A0E32A40-B5B6-4BC3-8E72-6887B0C13D43 Q36813547-4A1B1851-8979-448F-BFF0-929D94455484 Q38801550-E781121A-594F-480B-B398-2537821D774A Q38855423-E1F2FD33-83F9-46A4-9A5C-86E90E61A3AA Q39079514-BC1D93AF-22D2-4526-BF54-C88103C071CE Q40151311-926138D9-D751-4521-BECB-18CEB2706A89 Q41929326-C6921E04-449E-4BCF-B243-407ECA49A17E Q44606374-024E0202-B60C-4348-9ED0-388032F3DCF2

P2860

The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90

http://www.wikidata.org/entity/Q33466002

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The immunosuppressive properti ...... highly conserved residue, R90

@ast

The immunosuppressive properti ...... highly conserved residue, R90

@en

type

label

The immunosuppressive properti ...... highly conserved residue, R90

@ast

The immunosuppressive properti ...... highly conserved residue, R90

@en

prefLabel

The immunosuppressive properti ...... highly conserved residue, R90

@ast

The immunosuppressive properti ...... highly conserved residue, R90

@en

P1433

Q33466002-94D525E2-367B-403D-B316-5A376CC9577A

P1476

Q33466002-BA431A98-7AD7-4936-A726-56156B684545

P2093

Q33466002-06C0700E-AFE5-4A3C-B13C-E9545C8683E7

Q33466002-2F6AA8F7-AE57-4A4C-8AF3-898F72AF6553

Q33466002-4C46A788-B139-4A1C-BBF1-3B52CD0CE52E

Q33466002-718AA5DE-B525-4F77-89AA-BDC31DA04E01

Q33466002-B3CBF249-6FF4-408F-BDB6-43EA2A452939

Q33466002-C5FCBD63-AE31-43DB-B926-7456FC1C624F

Q33466002-D7ED4B58-B1E5-4B6E-B78E-10E25D46144F

Q33466002-E7531EED-9BC8-4BB2-8A8F-5F24365147DE

Q33466002-FCE89026-DAB2-428C-9633-8C87B8625837

P2860

Q33466002-0E6DEDE1-7CFB-4FB7-A1C8-871734997A9D

Q33466002-24E97D4F-F0FC-442A-B022-6793B5CB4621

Q33466002-2663ACE8-04B3-4D5F-9CCF-79122B567AB4

Q33466002-2F32C9A1-3870-4E8D-8B0C-45778DFB5EA3

Q33466002-49BFD133-441B-4C78-80A0-01E9A1B2970C

Q33466002-61760DC5-C1C9-4AA4-AD10-3EFBCE92639F

Q33466002-6240BC30-B6DA-446E-BD07-F6C888E811CC

Q33466002-6560EA81-30BB-4361-A7CB-2C7B6268A0FB

Q33466002-66D66B63-2824-45C8-B21A-3DDF69ABD45E

Q33466002-7490AABC-1AC1-47B6-9A9F-0D24E95A47F4

P304

Q33466002-68316373-6058-4F80-BAD6-CD58A2129C81

P31

Q33466002-1A24FAFC-C16B-4146-A1B9-A22C917B5D41

P356

Q33466002-8461522A-9D1C-4E4F-89B3-A6A8A71D1CE6

P407

Q33466002-9E5C6092-7029-4311-8182-122950A0DCE4

P433

Q33466002-0ECE200A-8386-4F8E-BDF4-4A523B4E50DF

P478

Q33466002-FE9D8D1C-16FB-468B-827F-30BC0BE1F534

P577

Q33466002-FE1D7F53-7EF2-4D34-A2A9-4B04A80ECA20

P5875

Q33466002-BB9C9279-9112-4767-81CC-B1F8A6BD066A

P698

Q33466002-650AD1E6-B1E7-4B7C-B056-938C899088F6

P932

Q33466002-077FF3B0-CFCB-4AA0-AFE8-E507DCC3F5CE

P356

JOURNAL.PONE.0005853

P1433

P1476

The immunosuppressive properti ...... highly conserved residue, R90

@en

P2093

Aijing Starr

http://www.w3.org/2001/XMLSchema#string

Brad Lackford

http://www.w3.org/2001/XMLSchema#string

Charles Nicolette

http://www.w3.org/2001/XMLSchema#string

David Calderhead

http://www.w3.org/2001/XMLSchema#string

Don Healey

http://www.w3.org/2001/XMLSchema#string

Irina Tcherepanova

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Routy

http://www.w3.org/2001/XMLSchema#string

Melissa D Adams

http://www.w3.org/2001/XMLSchema#string

Mohamed Rachid Boulassel

http://www.w3.org/2001/XMLSchema#string

P2860

The mitochondriotoxic domain of Vpr determines HIV-1 virulence

Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis

NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection

Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion.

Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.

Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells

Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.

HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection.

P304

e5853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0005853

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26283035

http://www.w3.org/2001/XMLSchema#string

P698

19516896

http://www.w3.org/2001/XMLSchema#string

P932

2689350

http://www.w3.org/2001/XMLSchema#string